Drug Safety Monitoring

Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problems.


India is a hub of generic products of medicines. In recent years, it has attained the status of Pharmacy of the World. It supplies medicines to more than 200 countries and vaccines to 160 countries. India is a vast socio-ethnic, biodiversity country with different healthcare facilities for its myriad masses.

Adverse Drug Reactions (ADR):

A response to a drug which is noxious and unintended that occurs at doses normally used in man for the prophylaxis, diagnosis or therapy of disease or for the modification of physiological function The Ministry of  Health and Family Welfare (MOHFW) of Government of India has designed a program called National Pharmacovigilance Program of India (PvPI) in the year 2010 under the supervision of Central Drug Standards Control Organization (CDSCD) and Drug Controller General of India (DCGI).

Currently, the Indian Pharmacopoeia Commission (IPC) is coordinating this nationwide activity as the National Coordinating Centre (NCC) of pharmacovigilance.

Pharmacovigilance (PV) Committee is functioning at DY Patil Deemed to be University, School of Medicine, Navi Mumbai.

It is a registered “Adverse Drug Monitoring Centre” (AMC) by the Indian Pharmacopoeia Commission (IPC), Ghaziabad.